PE20150403A1 - Pirrol carboxamidas fluorometilo sustituidas - Google Patents

Pirrol carboxamidas fluorometilo sustituidas

Info

Publication number
PE20150403A1
PE20150403A1 PE2015000264A PE2015000264A PE20150403A1 PE 20150403 A1 PE20150403 A1 PE 20150403A1 PE 2015000264 A PE2015000264 A PE 2015000264A PE 2015000264 A PE2015000264 A PE 2015000264A PE 20150403 A1 PE20150403 A1 PE 20150403A1
Authority
PE
Peru
Prior art keywords
pirrol
chlorophenyl
trifluoromethyl
benzyl
alkyl
Prior art date
Application number
PE2015000264A
Other languages
English (en)
Inventor
Stefan Schunk
Melanie Reich
Henning Steinhagen
Nils Damann
Philip Skone
Richard Hamlyn
Robert Kirby
Marc Rogers
Kathy Sutton
Michael Haurand
Achim Kless
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of PE20150403A1 publication Critical patent/PE20150403A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Referida a un compuesto derivado de carboxamida de formula (I), donde n es 0, 1 o 2; m es 0 o 1; X es O, S, NH, entre otros; R1, R2 y R3 son H, F, Cl, Br, CF3, entre otros; R4 es CH2F, CHF2, CF3; R5 es H, alquilo C1-C6, entre otros; R6, R7 y R8 son H, F, Cl, CF3, entre otros; R9 es H, alquilo C1-C6, entre otros; R10 es H, un residuo alifatico C1-C10, entre otros. Son compuestos preferidos: [1-Bencilo-3-(4-clorofenil)-5-(trifluorometilo)-1H-pirrol-2-il]-morfolino-4-il-metano, amida del acido 1-Bencilo-3-(4-clorofenil)-N-(2,2-dimetilo-propilo)-N-metilo-5-(trifluorometilo)-1H-pirrol-2-carboxilico, entre otros. Dichos compuestos son bloqueadores de canales de calcio activados por voltaje y son utiles en el tratamiento y/o profilaxis del dolor y otras enfermedades y/o trastornos
PE2015000264A 2012-08-29 2013-08-29 Pirrol carboxamidas fluorometilo sustituidas PE20150403A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12006120 2012-08-29

Publications (1)

Publication Number Publication Date
PE20150403A1 true PE20150403A1 (es) 2015-04-16

Family

ID=46851247

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2015000264A PE20150403A1 (es) 2012-08-29 2013-08-29 Pirrol carboxamidas fluorometilo sustituidas

Country Status (28)

Country Link
US (1) US9302988B2 (es)
EP (1) EP2906534B1 (es)
JP (1) JP6114392B2 (es)
KR (1) KR20150046321A (es)
CN (1) CN104755459A (es)
AR (1) AR092279A1 (es)
AU (1) AU2013307645B2 (es)
BR (1) BR112015004306A2 (es)
CA (1) CA2883242A1 (es)
CL (1) CL2015000460A1 (es)
CY (1) CY1118542T1 (es)
DK (1) DK2906534T3 (es)
EA (1) EA027640B1 (es)
EC (1) ECSP15007358A (es)
ES (1) ES2618520T3 (es)
HK (1) HK1212685A1 (es)
HR (1) HRP20170338T1 (es)
HU (1) HUE032691T2 (es)
IL (1) IL237393A (es)
LT (1) LT2906534T (es)
MX (1) MX2015002357A (es)
PE (1) PE20150403A1 (es)
PL (1) PL2906534T3 (es)
PT (1) PT2906534T (es)
RS (1) RS55702B1 (es)
SI (1) SI2906534T1 (es)
TW (1) TW201416348A (es)
WO (1) WO2014032801A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015011445A (es) 2013-03-15 2016-04-20 Global Blood Therapeutics Inc Compuestos y usos de estos para la modulacion de la hemoglobina.
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
AU2014365744A1 (en) * 2013-12-19 2016-05-26 Grunenthal Gmbh Fluoromethyl-substituted pyrrole carboxamides III
WO2015090600A1 (en) * 2013-12-19 2015-06-25 Grünenthal GmbH Fluoromethyl-substituted pyrrole carboxamides as cav2.2 calcium channel blockers
EP3083613A1 (en) 2013-12-19 2016-10-26 Grünenthal GmbH Fluoromethyl-substituted pyrrole carboxamides iv
TW201718557A (zh) * 2015-10-08 2017-06-01 歌林達有限公司 經吡唑基取代之四氫吡喃基碸
TW201726128A (zh) * 2015-10-08 2017-08-01 歌林達有限公司 經吡唑基取代之四氫哌喃基碸
WO2020140957A1 (en) * 2019-01-04 2020-07-09 Ascentage Pharma (Suzhou) Co., Ltd. Method for preparing sulfonamides drugs
WO2020144375A1 (en) * 2019-01-11 2020-07-16 Grünenthal GmbH Substituted pyrrolidine amides iii

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19963174A1 (de) * 1999-12-27 2001-07-12 Gruenenthal Gmbh Substituierte Pyrrol-Mannichbasen
US20050101657A1 (en) * 2001-12-28 2005-05-12 Takeda Chemical Industries Ltd. Androgen receptor antagonists
WO2004027042A2 (en) * 2002-09-23 2004-04-01 E. I. Du Pont De Nemours And Company Isolation and use of ryanodine receptors
DE10261130A1 (de) * 2002-12-20 2004-07-01 Grünenthal GmbH Arzneimittel enthaltend substituierte 2,5-Diaminomethyl-1H-pyrrole
DE102006027229A1 (de) 2006-06-09 2007-12-20 Grünenthal GmbH 1,3-Disubstituierte 4-Methyl-1H-pyrrol-2-carbonsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln
US9115132B2 (en) 2010-07-09 2015-08-25 Convergence Pharmaceuticals Limited Tetrazole compounds as calcium channel blockers

Also Published As

Publication number Publication date
CN104755459A (zh) 2015-07-01
US9302988B2 (en) 2016-04-05
HUE032691T2 (hu) 2017-10-30
LT2906534T (lt) 2017-02-27
BR112015004306A2 (pt) 2017-07-04
PT2906534T (pt) 2017-03-08
WO2014032801A1 (en) 2014-03-06
JP2015526488A (ja) 2015-09-10
IL237393A (en) 2017-02-28
RS55702B1 (sr) 2017-07-31
EP2906534A1 (en) 2015-08-19
HRP20170338T1 (hr) 2017-04-21
SI2906534T1 (sl) 2017-03-31
KR20150046321A (ko) 2015-04-29
TW201416348A (zh) 2014-05-01
JP6114392B2 (ja) 2017-04-12
CL2015000460A1 (es) 2015-05-29
DK2906534T3 (en) 2017-01-23
CA2883242A1 (en) 2014-03-06
HK1212685A1 (zh) 2016-06-17
CY1118542T1 (el) 2017-07-12
ECSP15007358A (es) 2015-12-31
EA201500270A1 (ru) 2015-07-30
AU2013307645A1 (en) 2015-04-16
EA027640B1 (ru) 2017-08-31
ES2618520T3 (es) 2017-06-21
MX2015002357A (es) 2015-06-05
US20140066426A1 (en) 2014-03-06
AR092279A1 (es) 2015-04-08
EP2906534B1 (en) 2016-12-07
AU2013307645B2 (en) 2017-03-30
PL2906534T3 (pl) 2017-06-30
IL237393A0 (en) 2015-04-30
EA201500270A8 (ru) 2016-01-29

Similar Documents

Publication Publication Date Title
PE20150403A1 (es) Pirrol carboxamidas fluorometilo sustituidas
PE20180177A1 (es) Derivados de 1-(het) arilsulfonil-(pirrolidin o piperidin)-2-carboxamida y su uso como antagonistas de trpa1
PE20140199A1 (es) 6-amino-nicotinamidas sustituidas como moduladores de kcnq2/3
MX359882B (es) Amidas como moduladores de canales de sodio.
PH12015501661B1 (en) Pyridone amides as modulators of sodium channels
PE20131350A1 (es) Compuestos sustituidos de benzamida
PH12015502192A1 (en) Novel compounds
TW201612158A (en) Amide derivatives and salts thereof, preparation process and pharmaceutical use thereof
PE20091843A1 (es) Inhibidores de catepsina c
PE20121640A1 (es) Derivados de pirazina como inhibidores de bace
EA201290519A1 (ru) Положительные аллостерические модуляторы рецептора хинолин амида m1
PE20150400A1 (es) Benzamidas n-sustituidas y su uso en el tratamiento del dolor
PE20120911A1 (es) Derivados de prolina como inhibidores de catepsina
MX368833B (es) Derivados de quinolina y quinazolina amidas como inhibidores de canales de sodio nav1.8 y el uso de los mismos en el tratamiento del dolor.
PE20091842A1 (es) Pirrolidinonas como activadores de glucoquinasa
PE20120076A1 (es) Amidas sustituidas del acido 4-(1,2,3,4-tetrahidroisoquinolin-2-il)-4-oxobutirico como moduladores de kcnq2/2
MY146662A (en) Novel n-(8-heteroaryltetrahydronaphtalene-2yl) or n-(5-heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
PE20120790A1 (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3
PE20140966A1 (es) Quinazolincarboxamida azetidinas
UA115881C2 (uk) Алкоксипіразоли як активатори розчинної гуанілатциклази
PE20140868A1 (es) Antagonistas trpm8 y su uso en tratamientos
PE20150709A1 (es) Benzamidas
MA34055B1 (fr) Chlorhydrate d'agomelatine hydrate et sa preparation
PE20151748A1 (es) Inhibidores de bace1
EA202090119A1 (ru) Аморфные и кристаллические формы ido-ингибиторов

Legal Events

Date Code Title Description
FD Application declared void or lapsed